As part of the acquisition, CentralReach will remain independent, preserving its team, brands, products and mission.
Roper Technologies (ROP) has reached a definitive agreement to acquire CentralReach from Insight Partners for a net purchase ...
As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...
Roper Technologies (ROP) said Monday that it agreed to acquire CentralReach, an autism therapy software provider, in a $1.65 billion deal that it expects to close within the next two months. Roper is ...
IIT Bombay students rate the Student Wellness Centre's mental health support as average, with calls for reforms and increased representation for better services.